Dépôt numérique
RECHERCHER

Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells

Téléchargements

Téléchargements par mois depuis la dernière année

Plus de statistiques...

Bhat, Mamatha, Yanagiya, Akiko, Graber, Tyson, Razumilava, Nataliya, Bronk, Steve, Zammit, Domenick, Zhao, Yunhao, Metrakos, Peter, Pollak, Michael, Sonenberg, Nahum, Gores, Gregory, Jaramillo, Maritza, Morita, Masahiro et Alain, Tommy (2017). Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells Oncotarget , vol. 8 , nº 31. p. 50542-50556. DOI: 10.18632/oncotarget.10671.

[thumbnail of Metformin requires 4E-BPs to induce apoptosis and repress.pdf]
Prévisualisation
PDF - Version publiée
Disponible sous licence Creative Commons Attribution.

Télécharger (8MB) | Prévisualisation

Résumé

Metformin inhibits the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, which is frequently upregulated in hepatocellular carcinoma (HCC). Metformin has also been shown to induce apoptosis in this cancer. Here, we investigate whether metformin-induced apoptosis in HCC is mediated by the downstream mTORC1 effectors eukaryotic initiation factor 4E and (eIF4E)-binding proteins (4E-BPs). Further, we ask whether changes in 4E-BPs activity during metformin treatment negatively regulate translation of the anti-apoptotic myeloid cell leukemia 1 (Mcl-1) mRNA. A genetic HCC mouse model was employed to assess the ability of metformin to reduce tumor formation, induce apoptosis, and control 4E-BP1 activation and Mcl-1 protein expression. In parallel, the HCC cell line Huh7 was transduced with scrambled shRNA (control) or shRNAs targeting 4E-BP1 and 4E-BP2 (4E-BP knock-down (KD)) to measure differences in mRNA translation, apoptosis, and Mcl-1 protein expression after metformin treatment. In addition, immunohistochemical staining of eIF4E and 4E-BP1 protein levels was addressed in a HCC patient tissue microarray. We found that metformin decreased HCC tumor burden, and tumor tissues showed elevated apoptosis with reduced Mcl-1 and phosphorylated 4E-BP1 protein levels. In control but not 4E-BP KD Huh7 cells, metformin induced apoptosis and repressed Mcl-1 mRNA translation and protein levels. Immunostaining of HCC patient tumor tissues revealed a varying ratio of eIF4E/4E-BP1 expression. Our results propose that metformin induces apoptosis in mouse and cellular models of HCC through activation of 4E-BPs, thus tumors with elevated expression of 4E-BPs may display improved clinical chemopreventive benefit of metformin.

Type de document: Article
Mots-clés libres: 4E-BPs; hepatocellular carcinoma; mRNA translation; mTORC1; metformin
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 27 sept. 2017 15:56
Dernière modification: 27 sept. 2017 15:56
URI: https://espace.inrs.ca/id/eprint/5944

Actions (Identification requise)

Modifier la notice Modifier la notice